EUR 13.06
(1.08%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 128.02 Million EUR | 10.64% |
2022 | 115.71 Million EUR | 24.18% |
2021 | 93.18 Million EUR | -2.58% |
2020 | 95.64 Million EUR | 5.37% |
2019 | 90.77 Million EUR | -2.58% |
2018 | 93.18 Million EUR | 3.32% |
2017 | 90.18 Million EUR | -17.98% |
2016 | 109.95 Million EUR | 131.78% |
2015 | 47.44 Million EUR | -38.71% |
2014 | 77.4 Million EUR | -16.65% |
2013 | 92.87 Million EUR | -5.17% |
2012 | 97.93 Million EUR | -3.24% |
2011 | 101.21 Million EUR | -25.24% |
2010 | 135.39 Million EUR | 35.09% |
2009 | 100.22 Million EUR | 5.25% |
2008 | 95.22 Million EUR | 51.62% |
2007 | 62.8 Million EUR | 115.57% |
2006 | 29.13 Million EUR | -37.55% |
2005 | 46.65 Million EUR | 1.73% |
2004 | 45.86 Million EUR | -37.07% |
2003 | 72.87 Million EUR | -12.95% |
2002 | 83.72 Million EUR | 3.26% |
2001 | 81.07 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 72.79 Million EUR | 0.0% |
2023 FY | 128.02 Million EUR | 10.64% |
2023 Q4 | 62.69 Million EUR | 0.0% |
2023 Q2 | 65.33 Million EUR | 0.0% |
2022 Q4 | 57.7 Million EUR | 0.0% |
2022 Q2 | 58.01 Million EUR | 0.0% |
2022 FY | 115.71 Million EUR | 24.18% |
2021 Q4 | 48.78 Million EUR | 0.0% |
2021 FY | 93.18 Million EUR | -2.58% |
2021 Q2 | 44.39 Million EUR | 0.0% |
2020 Q2 | 44.88 Million EUR | 0.0% |
2020 Q4 | 50.76 Million EUR | 0.0% |
2020 FY | 95.64 Million EUR | 5.37% |
2019 FY | 90.77 Million EUR | -2.58% |
2019 Q2 | 36.09 Million EUR | 0.0% |
2019 Q4 | 56.95 Million EUR | 0.0% |
2018 Q2 | 35.68 Million EUR | 0.0% |
2018 FY | 93.18 Million EUR | 3.32% |
2017 FY | 90.18 Million EUR | -17.98% |
2017 Q2 | 55.39 Million EUR | 0.0% |
2016 Q4 | 56.41 Million EUR | 0.0% |
2016 FY | 109.95 Million EUR | 131.78% |
2016 Q2 | 53.54 Million EUR | 0.0% |
2015 Q2 | 39.37 Million EUR | 0.0% |
2015 Q4 | 8.06 Million EUR | 0.0% |
2015 FY | 47.44 Million EUR | -38.71% |
2014 Q2 | 38.33 Million EUR | 0.0% |
2014 FY | 77.4 Million EUR | -16.65% |
2013 Q4 | 53.38 Million EUR | 0.0% |
2013 FY | 92.87 Million EUR | -5.17% |
2013 Q2 | 39.48 Million EUR | 0.0% |
2012 FY | 97.93 Million EUR | -3.24% |
2012 Q4 | 2.88 Million EUR | 1394.56% |
2012 Q3 | 193 Thousand EUR | 0.0% |
2012 Q2 | 193 Thousand EUR | 0.0% |
2012 Q1 | 193 Thousand EUR | 0.0% |
2011 Q2 | 3.46 Million EUR | 0.0% |
2011 Q4 | 193 Thousand EUR | -94.43% |
2011 FY | 101.21 Million EUR | -25.24% |
2011 Q3 | 3.46 Million EUR | 0.0% |
2011 Q1 | 3.46 Million EUR | 0.0% |
2010 Q3 | 971.75 Thousand EUR | 0.0% |
2010 FY | 135.39 Million EUR | 35.09% |
2010 Q4 | 3.46 Million EUR | 256.5% |
2010 Q1 | 971.75 Thousand EUR | 0.0% |
2010 Q2 | 971.75 Thousand EUR | 0.0% |
2009 FY | 100.22 Million EUR | 5.25% |
2009 Q3 | -339.75 Thousand EUR | 0.0% |
2009 Q2 | -339.75 Thousand EUR | 0.0% |
2009 Q4 | 971.75 Thousand EUR | 386.02% |
2009 Q1 | -339.75 Thousand EUR | 0.0% |
2008 FY | 95.22 Million EUR | 51.62% |
2008 Q4 | -339.75 Thousand EUR | 78.63% |
2008 Q3 | -1.58 Million EUR | 0.0% |
2008 Q2 | -1.58 Million EUR | 0.0% |
2008 Q1 | -1.58 Million EUR | 0.0% |
2007 Q4 | -1.58 Million EUR | -233.93% |
2007 FY | 62.8 Million EUR | 115.57% |
2007 Q1 | 1.18 Million EUR | 0.0% |
2007 Q2 | 1.18 Million EUR | 0.0% |
2007 Q3 | 1.18 Million EUR | 0.0% |
2006 FY | 29.13 Million EUR | -37.55% |
2006 Q4 | 1.18 Million EUR | 245.81% |
2006 Q2 | 343.25 Thousand EUR | 0.0% |
2006 Q1 | 343.25 Thousand EUR | 0.0% |
2006 Q3 | 343.25 Thousand EUR | 0.0% |
2005 Q2 | 4.52 Million EUR | 0.0% |
2005 Q3 | 4.52 Million EUR | 0.0% |
2005 FY | 46.65 Million EUR | 1.73% |
2005 Q4 | 343.25 Thousand EUR | -92.42% |
2005 Q1 | 4.52 Million EUR | 0.0% |
2004 Q2 | 2.12 Million EUR | 0.0% |
2004 Q4 | 4.52 Million EUR | 112.75% |
2004 FY | 45.86 Million EUR | -37.07% |
2004 Q1 | 2.12 Million EUR | 0.0% |
2004 Q3 | 2.12 Million EUR | 0.0% |
2003 Q1 | -2.07 Million EUR | 0.0% |
2003 Q4 | 2.12 Million EUR | 202.55% |
2003 Q2 | -2.07 Million EUR | 0.0% |
2003 Q3 | -2.07 Million EUR | 0.0% |
2003 FY | 72.87 Million EUR | -12.95% |
2002 Q4 | -2.07 Million EUR | 12.85% |
2002 Q3 | -2.38 Million EUR | 0.0% |
2002 Q1 | -2.38 Million EUR | 0.0% |
2002 Q2 | -2.38 Million EUR | 0.0% |
2002 FY | 83.72 Million EUR | 3.26% |
2001 FY | 81.07 Million EUR | 0.0% |
2001 Q4 | -2.38 Million EUR | 30.05% |
2001 Q3 | -3.4 Million EUR | 0.0% |
2001 Q1 | -3.4 Million EUR | 0.0% |
2001 Q2 | -3.4 Million EUR | 0.0% |
2000 Q4 | -3.4 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | -978.915% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -1119088.74% |
Carmat SA | 21.54 Million EUR | -494.134% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | -607.002% |
Euromedis Groupe | 17.6 Million EUR | -627.028% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | -170.395% |
Ikonisys S.A. | 2.44 Million EUR | -5126.417% |
Implanet S.A. | 9.29 Million EUR | -1277.936% |
Median Technologies SA | 46.34 Million EUR | -176.259% |
SpineGuard SA | 7.35 Million EUR | -1640.604% |
Theraclion SA | -1.08 Million EUR | 11949.85% |
Euroapi S.A. | 398.9 Million EUR | 67.906% |
Guerbet SA | 550.79 Million EUR | 76.757% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 97.81% |
Sequana Medical NV | 30.03 Million EUR | -326.185% |